Med. praxi. 2022;19(5):362-366 | DOI: 10.36290/med.2022.056

Modern therapeutic modalities in insomnia

MUDr. Jakub Vaněk
Klinika psychiatrie Fakultní nemocnice Olomouc

Insomnia in various forms is among the most common complaints that bring patients to the offices of general practitioners and specialists. Prevalence studies indicate the incidence of insomnia in the adult population in a wide range of 6.2-40 % per calendar year. Advances in sleep neurobiology research reveal new cognitive and neurophysiological models of the etiopathogenesis of insomnia. Modern recommended guidelines in the treatment of insomnia emphasize the need to gradually take the steps in the therapy from less burdensome and mainly non-pharmacological interventions to pharmacological treatment. The primary treatment intervention should be psychotherapy, especially cognitive behavioral therapy with a module developed specifically for the treatment of insomnia. When non-pharmacological interventions fail, a wide range of drugs can be used. There is also a shift away from traditional and widely used 3rd generation hypnotics towards non-addictive alternative options including modern resynchronization therapy using synthetic melatonin.

Keywords: insomnia, sleep, CBT, hypnotics, insomnia.

Accepted: November 22, 2022; Published: November 29, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Vaněk J. Modern therapeutic modalities in insomnia. Med. praxi. 2022;19(5):362-366. doi: 10.36290/med.2022.056.
Download citation

References

  1. Dopheide JA. Insomnia overview: epidemiology, pathophysiology, diagnosis and monitoring, and nonpharmacologic therapy. Am J Manag Care. 2020;26(4 Suppl):S76-S84. doi: 10.37765/ajmc.2020.42769. PMID: 32282177. Go to original source... Go to PubMed...
  2. Roth T, Coulouvrat C, Hajak G, et al. Prevalence and perceived health associated with insomnia based on DSM­‑IV­‑TR; International Statistical Classification of Diseases and Related Health Problems, Tenth Revision; and Research Diagnostic Criteria/International Classification of Sleep Disorders, Second Edition criteria: results from the America Insomnia Survey. Biol Psychiatry. 2011;69(6):592-600. doi: 10.1016/j.biopsych.2010. 10. 023. Epub 2010 Dec 31. PMID: 21195389. Go to original source... Go to PubMed...
  3. Kessler RC, Berglund PA, Coulouvrat C, et al. Insomnia and the performance of US workers: results from the America insomnia survey. Sleep. 2011;34(9):1161-1171. Go to original source... Go to PubMed...
  4. Hafner M, Stepanek M, Taylor J, et al. Why Sleep Matters­‑The Economic Costs of Insufficient Sleep: A Cross­‑Country Comparative Analysis. Rand Health Q. 2017;6(4):11. PMID: 28983434; PMCID: PMC5627640. Go to original source...
  5. Zheng B, Yu C, Lv J, et al; China Kadoorie Biobank Collaborative Group. Insomnia symptoms and risk of cardiovascular diseases among 0.5 million adults: A 10-year cohort. Neurology. 2019;93(23):e2110-e2120. doi: 10.1212/WNL.0000000000008581. Epub 2019 Nov 6. PMID: 31694922; PMCID: PMC6937485. Go to original source... Go to PubMed...
  6. Harvey AG. A cognitive model of insomnia. Behav Res Ther. 2002;40(8):869-93. doi: 10.1016/s0005-7967(01)00061-4. PMID: 12186352. Go to original source... Go to PubMed...
  7. Bonnet MH, Arand DL. Hyperarousal and insomnia: state of the science. Sleep Med Rev. 2010;14(1):9-15. doi: 10.1016/j.smrv.2009. 05. 002. Epub 2009 Jul 28. PMID: 19640748. Go to original source...
  8. Taylor DJ, Pruiksma KE. Cognitive and behavioural therapy for insomnia (CBT­‑I) in psychiatric populations: a systematic review. Int Rev Psychiatry. 2014;26(2):205-13. doi: 10.3109/09540261.2014.902808. PMID: 24892895. Go to original source... Go to PubMed...
  9. Sateia MJ. International classification of sleep disorders­‑third edition: highlights and modifications. Chest. 2014;146(5): 1387-1394. doi: 10.1378/chest.14-0970. PMID: 25367475. Go to original source... Go to PubMed...
  10. Šonka K, Espa­‑Červená K. Primární insomnie dospělých - b) terapie. In: Raboch J, Uhlíková P, Hellerová P, Anders M, Šusta M (eds). Psychiatrie: Doporučené postupy psychiatrické péče 5. Praha: (cited 18. 7. 2022) Available from: https://postupy­‑pece.psychiatrie.cz/specialni­‑psychiatrie/f5-poruchy­‑prijmu­‑potravy/insomnie­‑dospeli­‑terapie.
  11. Pretl M, Smolík P, Konštacký S. Nespavost. Doporučené diagnostické a terapeutické postupy pro všeobecné praktické lékaře: novelizace 2017. Praha: Společnost všeobecného lékařství ČLS JEP - Centrum doporučených postupů pro praktické lékaře; 2017:13.
  12. Morin CH, Davidson JR, Beaulieu­‑Bonneau. Cognitive bahevior therapies for insomnia I: Approches and efficacy In: Kryger M, Roth T (eds). Principles and practice of sleep medicine. 6th ed. Elsevier, Philadelphia, 2017:804-813. Go to original source...
  13. Wiegand MH. Antidepressants for the treatment of insomnia: a suitable approach? Drugs. 2008;68:2411-2417. Go to original source... Go to PubMed...
  14. Morgan K, Kucharczyk E, Gregory P. Insomnia: evidence­‑based approaches to assessment and management. Clin Med (Lond). 2011;11(3):278-81. doi: 10.7861/clinmedicine.11-3-278. PMID: 21902086; PMCID: PMC4953326. Go to original source... Go to PubMed...
  15. Espa Červená K, Závěšická L, Praško J. KBT insomnie. In: Praško J, Možný P, Slepecký M (eds). Kognitivne behaviorálni terapie psychických poruch. Praha: Triton; 2007: 734-763.
  16. Wise J. Insomnia: NICE recommends digital app as treatment option BMJ 2022;377:o1268 doi:10.1136/bmj.o1268. Go to original source...
  17. Hoyer D, Allen A, Jacobson LH. Hypnotics with novel modes of action. Br J Clin Pharmacol. 2020;86(2): 244-249. doi: 10.1111/bcp.14180. Epub 2020 Jan 17. PMID: 31756268; PMCID: PMC7015741. Go to original source... Go to PubMed...




Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.